Pfizer and Bain Capital Create Cerevel Therapeutics
- Posted by ISPE Boston
- On October 24, 2018
Bain Capital and Pfizer have announced the creation of Cerevel Therapeutics, a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS) to be headquartered in the greater Boston area. Pfizer is contributing a portfolio of pre-commercial neuroscience assets to Cerevel, which include three clinical-stage compounds and several […]
Read More